Published on in Vol 9, No 2 (2021): February
1 Department of Population Health Sciences, Duke University, Durham, NC, United States
2 Clinical Trials Transformation Initiative, Durham, NC, United States
3 Patient and Partners LLC, Madison, CT, United States
4 Department of Medicine, Division of Hematology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
5 Lineberger Comprehensive Cancer Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
6 Genentech, Inc., San Francisco, CA, United States
7 Office of Health and Constituent Affairs, US Public Health Service, US Food and Drug Administration, Silver Spring, MD, United States
8 Duke Clinical Research Institute, Duke University, Durham, NC, United States
*all authors contributed equally